Literature DB >> 22336244

The times they are a-changin': time to change glaucoma management.

Anders Heijl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22336244     DOI： 10.1111/j.1755-3768.2011.02328.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  3 in total

Review 1.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

2.  Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model.

Authors:  Emiel Geeraerts; Marie Claes; Eline Dekeyster; Manuel Salinas-Navarro; Lies De Groef; Chris Van den Haute; Isabelle Scheyltjens; Veerle Baekelandt; Lutgarde Arckens; Lieve Moons
Journal:  J Neurosci       Date:  2019-01-17       Impact factor: 6.167

3.  A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  Stefan Pfennigsdorf; Leo de Jong; Stefan Makk; Yvette Fournichot; Alain Bron; Robert J Morgan-Warren; John Maltman
Journal:  Clin Ophthalmol       Date:  2013-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.